DKC1 and prostate cancer: Finally, a defect in rRNA posttranscriptional modifications may cause specific clinical syndromes and may be associated with a higher incidence of cancer, which is the case for DKC1 mutation related to X-linked dyskeratosis congenita (X-DC), and for Dyskerin overexpressed in prostate cancer [52–55].